Hear from the best minds in employee health on Season 2 of The Benefits Playbook podcast! 🎙️ Listen now

Search Collective Health


Schedule a demo my-collective-icon-2022

Pharmacogenomics and personalized pharmacy study with Jessica Lea

In this episode of The Benefits Playbook, guest Jessica Lea explains the revolutionary study of pharmacogenomics and its impact on patients.

CH-2024_S2_podcast_Share image_1400x800

The Benefits Playbook is a podcast covering all things employee healthcare, brought to you by Collective Health. Each episode features an in-depth conversation between Sasha Yamaguchi, Commercial Leader at Collective Health, and an expert in the health benefits industry.

This episode of The Benefits Playbook features an interview with Jessica Lea, founder and CEO of Tria Health. Jessica is passionate about pharmacists providing patient-centered care to improve the health outcomes of patients. She has a Doctor of Pharmacy degree from the University of Missouri-Kansas City, maintains board certification in psychiatric pharmacy, and has an Executive Masters in Business from Rockhurst University. Jessica is a healthcare innovator and has been recognized as one of the PharmaVOICE100.

In this episode, host Sasha Yamaguchi sits down with Jessica to discuss the revolutionary study of pharmacogenomics, the craze around weight loss drugs, and Tria Health’s impact.

“We’re starting to get to a place where we have a better understanding of more medications that we know are affected by the way in which your body may metabolize or not metabolize the medicine, as it relates specifically to your DNA.”

– Jessica Lea

Highlights from Jessica’s episode include:

  • Jessica’s career background
  • How Tria Health supports its members
  • Pharmacogenomics
  • Jessica’s take on weight loss drugs

Listen to the full episode above, or on Apple Podcasts, Spotify, or your favorite podcast platform. 

Read the episode transcript here.

Post Topics:

Let’s be friends (with benefits!)
Join our newsletter

Collective Health